Viatris (VTRS) Is Up 10.6% After Q1 Beat, CFO Change And Outlook Reaffirmation - What's Changed

Simply Wall St.05-13

Viatris Inc. recently reported first-quarter 2026 results, with revenue rising to US$3,517.0 million and net income reaching US$176.4 million, while reaffirming full-year 2026 revenue guidance of US$...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2635273548?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","is_english":true,"pubTime":"2026-05-13 08:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2635273548","market":"nz","top_or_hot":-1,"title":"Viatris (VTRS) Is Up 10.6% After Q1 Beat, CFO Change And Outlook Reaffirmation - What's Changed","media":"Simply Wall St.","content":"<div>\n<p>Viatris Inc. recently reported first-quarter 2026 results, with revenue rising to US$3,517.0 million and net income reaching US$176.4 million, while reaffirming full-year 2026 revenue guidance of US$...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vtrs/viatris/news/viatris-vtrs-is-up-106-after-q1-beat-cfo-change-and-outlook\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Viatris (VTRS) Is Up 10.6% After Q1 Beat, CFO Change And Outlook Reaffirmation - What's Changed</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nViatris (VTRS) Is Up 10.6% After Q1 Beat, CFO Change And Outlook Reaffirmation - What's Changed\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-13 08:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vtrs/viatris/news/viatris-vtrs-is-up-106-after-q1-beat-cfo-change-and-outlook><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Viatris Inc. recently reported first-quarter 2026 results, with revenue rising to US$3,517.0 million and net income reaching US$176.4 million, while reaffirming full-year 2026 revenue guidance of US$...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vtrs/viatris/news/viatris-vtrs-is-up-106-after-q1-beat-cfo-change-and-outlook\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VTRS","symbol_name":"Viatris Inc.","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vtrs/viatris/news/viatris-vtrs-is-up-106-after-q1-beat-cfo-change-and-outlook","article_id":"2635273548","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vtrs/viatris/news/viatris-vtrs-is-up-106-after-q1-beat-cfo-change-and-outlook","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2635273548","pubTimestamp":1778633642,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Viatris Inc. recently reported first-quarter 2026 results, with revenue rising to US$3,517.0 million and net income reaching US$176.4 million, while reaffirming full-year 2026 revenue guidance of US$14.45 billion to US$14.95 billion and maintaining its quarterly dividend of US$0.1200 per share.\nAlongside these results, the company announced the upcoming departure of Chief Financial Officer Theodora “Doretta” Mistras and the appointment of long-time finance executive Paul Campbell as interim...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"VTRS":"Viatris Inc.","BK4588":"碎股","BK4007":"制药","LU1839511570.USD":"WELLS FARGO GLOBAL FACTOR ENHANCED EQUITY \"I\" (USD) ACC","BK4583":"猴痘概念","BK4585":"ETF&股票定投概念","LU2087621335.USD":"ALLSPRING GLOBAL FACTOR ENHANCED EQUITY \"A\" (USD) ACC"},"translate_title":"Viatris(VTRS)在第一季度表现、首席财务官变动和前景重申后上涨10.6%-发生了什么变化","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VTRS":1.5},"content_text":"Viatris Inc. recently reported first-quarter 2026 results, with revenue rising to US$3,517.0 million and net income reaching US$176.4 million, while reaffirming full-year 2026 revenue guidance of US$14.45 billion to US$14.95 billion and maintaining its quarterly dividend of US$0.1200 per share. Alongside these results, the company announced the upcoming departure of Chief Financial Officer Theodora “Doretta” Mistras and the appointment of long-time finance executive Paul Campbell as interim CFO, a governance shift that may influence how investors view its reaffirmed outlook and cost-discipline efforts. We’ll now examine how Viatris’ stronger first-quarter profitability and reaffirmed 2026 revenue outlook affect the existing investment narrative for the company. Uncover the next big thing with 27 elite penny stocks that balance risk and reward.AdvertisementViatris Investment Narrative RecapTo stay invested in Viatris, you need to believe that management can use a broad, off patent portfolio and disciplined costs to turn volatile earnings into steadier cash generation. The latest quarter’s move from a heavy loss to positive net income and the reaffirmed 2026 revenue range support that thesis, while the key near term catalyst remains execution against guidance. The biggest current risk is that persistent pricing and regulatory pressure still undermines margins, and this update does not remove that concern. The most relevant recent announcement here is the CFO transition. With Theodora “Doretta” Mistras exiting and long serving finance leader Paul Campbell stepping in as interim CFO, investors may watch closely for any shift in how Viatris manages costs, capital allocation and its reaffirmed US$14.45 billion to US$14.95 billion revenue target, especially after a quarter that highlights how sensitive the story is to both operational discipline and accounting quality. Yet behind those improving numbers, there is still the risk that heavier debt and ongoing pricing pressure could quietly limit Viatris’ financial flexibility in ways investors should be aware of... Read the full narrative on Viatris (it's free!)Viatris' narrative projects $15.3 billion revenue and $1.2 billion earnings by 2029. This requires 2.3% yearly revenue growth and a $4.7 billion earnings increase from -$3.5 billion today.Uncover how Viatris' forecasts yield a $15.72 fair value, a 8% downside to its current price.Exploring Other PerspectivesVTRS 1-Year Stock Price Chart Some of the lowest estimating analysts were assuming Viatris revenues would slip to about US$14.3 billion and earnings only reach around US$94 million, which is far more cautious than the base case. When you set those assumptions against a strong first quarter and concerns about rising regulatory costs, it shows how widely your view on risk and reward can differ and why it may be worth exploring several alternative narratives before deciding where you stand.Explore 7 other fair value estimates on Viatris - why the stock might be worth 39% less than the current price!The Verdict Is YoursDon't just follow the ticker - dig into the data and build a conviction that's truly your own.A great starting point for your Viatris research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.Our free Viatris research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Viatris' overall financial health at a glance.Ready To Venture Into Other Investment Styles?Every day counts. These free picks are already gaining attention. See them before the crowd does:We've uncovered the 13 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.Find 45 companies with promising cash flow potential yet trading below their fair value.The latest GPUs need a type of rare earth metal called Neodymium and there are only 33 companies in the world exploring or producing it. Find the list for free.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2635273548","isCrawlerRequest":true}